Jean-Jacques Kiladjian, MD, PhD^1,2,3, Jean-Christophe Ianotto, MD, PhD^4*, Juliette Soret, MD^5*, Nabih Maslah, PharmD, PhD^6,7*, Cendrine Chaffaut^8*, Françoise Boyer perrard^9*, Fiorenza Barraco, MD^10*, Viviane Dubruille, MD^11*, Claude Capron^12*, Amandine Tisserand^13*, Valérie Rolland-Neyret^14*, Zineb Ghrieb, PharmD^5*, Sylvie Chevret, MD, PhD^15*, Isabelle Plo^16*, Marie-Hélène Schlageter, PharmD, PhD^17*, Veronique Meignin^18*, Matthieu Resche-Rigon, MD, PhD^19* and Bruno Cassinat, PhD, PharmD²⁰

¹French Intergroup of Myeloproliferative neoplasms, FIM collaborative group, Paris, France
²Centre d'Investigations Cliniques (INSERM CIC 1427), AP-HP, Hôpital Saint-Louis, Université Paris Cité, Paris, France
³Saint-Louis Research Institute, INSERM UMR 1131, Paris, France
⁴Centre Hospitalier Universitaire, Brest, France
⁵Centre d'Investigations Cliniques, APHP, Hopital Saint-Louis, Paris, France
⁶Université de Paris, Cellular biology Department, Saint-Louis hospital, APHP, Paris, France
⁷IRSL, INSERM UMR 1131, Paris, France
⁸Division of Biostatistics, Saint-Louis Hospital, APHP, Paris, France
⁹Service des maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
¹⁰Department of Hematology, Centre Hospitalier Lyon Sud, Pierre Bénite, France
¹¹Hematology Department, Nantes University Hospital, Nantes, France
¹²AP-HP Hopital Ambroise Paré, Boulogne, FRA
¹³Gustave Roussy, INSERM, UMR1170, Villejuif, France
¹⁴CHU de Grenoble, Grenoble, France
¹⁵Division of Biostatistics, Saint-Louis Hospital, APHP, Paris, France, Paris, France
¹⁶INSERM UMR1170, Gustave Roussy, Villejuif, FRA
¹⁷Service de Biologie Cellulaire, Hôpital Saint-Louis AP-HP, PARIS, France
¹⁸APHP, Hopital Saint-Louis, Anatomo-pathologie, PARIS, France
¹⁹Medical informatics and biostatistics department, CHU Saint-Louis, Paris, France
²⁰Service de Biologie Cellulaire, APHP, Hopital Saint-Louis, Inserm UMRS1131, IRSL, Paris, FRA

Abdulraheem Yacoub, MD¹, Uma Borate, MD², Raajit K Rampal, MD, PhD³, Haris Ali, MD⁴, Eunice Wang, MD^5*, Aaron T. Gerds, MD, MS⁶, Gabriela S. Hobbs, MD⁷, Marina Kremyanskaya, MD, PhD⁸, Elliott Winton, MD⁹, Casey O’Connell, MD^10*, Swati Goel, MD^11*, Stephen T Oh, MD, PhD¹², Gary J. Schiller, MD¹³, Albert Assad, MD^14*, Sue Erickson-Viitanen, PhD^14*, Feng Zhou, PhD^14* and Naval Daver, MD¹⁵

¹University of Kansas Cancer Center, Westwood, KS
²Oregon Health & Science University, Portland, OR
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴City of Hope Medical Center, Duarte, CA
⁵Roswell Park Cancer Institute, BUFFALO, NY
⁶Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁷Massachusetts General Hospital, Boston, MA
⁸Icahn School of Medicine at Mount Sinai, New York, NY
⁹Emory University, Atlanta, GA
¹⁰University of Southern California, Los Angeles, CA
¹¹Montefiore Medical Center, Bronx, NY
¹²Washington University School of Medicine, St. Louis, MO
¹³David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
¹⁴Incyte Corporation, Wilmington, DE
¹⁵University of Texas MD Anderson Cancer Center, Houston, TX

Francesco Passamonti, MD^1*, James M. Foran, MD², Anand Tandra, MD^3*, Valerio De Stefano, MD^4,5*, Maria Laura Fox, MD^6*, Ahmad H. Mattour, MD⁷, Mary Frances McMullin, MD, FRCPath, FRCP⁸, Andrew Charles Perkins, MBBS, PhD, FRACP, FRCPA⁹, Gabriela Rodríguez-Macias, MD^10*, Hassan Sibai, MBBS, MD^11*, Qin Qin, PhD^12*, Yan Sun, PhD^12*, Jalaja Potluri, MD¹², Jason Harb, PhD^12* and Jonathan How, MD¹³

¹Division of Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, University of Insubria, Varese, VA, Italy
²Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
³Indiana Blood and Marrow Transplant, Indianapolis, IN
⁴Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy
⁵Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
⁶Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron. Barcelona, Spain, Barcelona, Spain
⁷Henry Ford Hospital, Detroit, MI
⁸Centre for Medical Education, Queens University, Belfast, United Kingdom
⁹Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
¹⁰Department of Hematology, Gregorio Marañón General University Hospital (HGUGM), Madrid, Spain
¹¹Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹²AbbVie Inc., North Chicago, IL
¹³McGill University, Montreal, QC, CAN

John Mascarenhas, MD¹, Marina Kremyanskaya, MD, PhD², Andrea Patriarca, MD^3*, Vikas Gupta, MD, FRCP, FRCPath⁴, Francesca Palandri, PhD, MD^5*, Timothy Devos, MD, PhD⁶, Raajit K Rampal, MD, PhD⁷, Moshe Talpaz, MD⁸, Alessandro Vannucchi, MD⁹, Andrew Kuykendall, MD¹⁰, Jean-Jacques Kiladjian, MD¹¹, Srdan Verstovsek, MD, PhD¹², Ruben Mesa, MD, FACP¹³, Gozde Colak, PhD^14*, Qing Li, PhD^15*, Sandra Klein, PhD^14* and Claire N. Harrison, DM¹⁶

¹Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
²Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³Hematology Unit, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy
⁴Department of Medicine, University of Toronto, Toronto, ON, Canada
⁵IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
⁶University Hospitals Leuven and Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium
⁷Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
⁸University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁹Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy
¹⁰Department of Malignant Hematology, H. Lee Mofitt Cancer Center, Tampa, FL
¹¹Hôpital Saint-Louis, Université de Paris, Paris, France
¹²MD Anderson Cancer Center, Houston, TX
¹³Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
¹⁴Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, MA
¹⁵MorphoSys US, Inc., Boston, MA
¹⁶Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

Florian H Heidel, MD^1*, Andrew Charles Perkins, MBBS, PhD², Andreas Reiter, MD³, Carl C. Crodel, MD^4*, Caroline Hasselbalch Riley, MD, PhD^5*, María Teresa Gómez-Casares, MD, PhD^6*, Istvan Takacs, MD^7*, Heiko Becker, MD^8*, Thomas Lehmann, MD^9*, Olga Vinogradova, MD, PhD^10,11,12*, Kate Burbury, MBBS, FRACP, FRCPA, DPhil^13*, Alessandro M. Vannucchi, MD^14*, Vikas Gupta, MD, FRCP, FRCPath¹⁵, Claire N. Harrison, DM¹⁶, Marielle Wondergem, MD, PhD¹⁷, Jean-Jacques Kiladjian, MD¹⁸, Grace Cleary, MPharm^19*, Angela Zhang, PhD^20*, Bruyère Mahuzier, PharmD^21*, Jagannath Kota, PhD^22*, Anirudh Prahallad, PhD^20* and David M Ross, MBBS, PhD, FRACP, FRCPA^23*

¹Klinik und Poliklinik für Innere Medizin C, Universitätsklinikum Greifswald, Greifswald, Germany
²Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
³Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
⁴Innere Medizin 2, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany
⁵Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
⁶Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
⁷Semmelweis University, Budapest, Hungary
⁸Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany
⁹Clinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
¹⁰Hematology Center of Botkin Hospital, Moscow, Russian Federation
¹¹Dmitry Rogachev National Research Center of Pediatric Hematology/Oncology and Immunology, Moscow, Russian Federation
¹²Pirogov Russian National Research Medical University, Moscow, Russian Federation
¹³Peter MacCallum Cancer Centre, Melbourne, Australia
¹⁴Center for Research and Innovation of Myeloproliferative Neoplasms – CRIMM, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
¹⁵Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
¹⁶Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
¹⁷Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands
¹⁸Hopital Saint-Louis, Paris, France
¹⁹Novartis Ireland Limited, Dublin, Ireland
²⁰Novartis Pharma AG, Basel, Switzerland
²¹Novartis Pharma S.A.S, Rueil-Malmaison, France
²²Novartis Healthcare Pvt. Ltd, Hyderabad, India
²³Royal Adelaide Hospital and SA Pathology, Adelaide, Australia

Firas El Chaer, MD¹, James McCloskey, MD^2*, Lindsay A.M. Rein, MD³, Randy A. Brown, MD⁴, Steven D. Green, MD^5*, Jeffrey J. Pu, MD, PhD⁶, Shuichi Shirane, MD, PhD^7*, Kazuya Shimoda, MD, PhD⁸, Michiko Ichii, MD, PhD^9*, Junichiro Yuda, MD, PhD^10*, Joseph Scandura, MD, PhD¹¹, Sujan Kabir, MD^12*, Jason M Foulks, PhD^13*, Jian Mei, PharmD^12*, Huyuan Yang, PhD^12*, Mark Wade, PhD^14*, Carl Stapinski, PharmD^12*, Claudia Lebedinsky, MD¹² and Raajit K Rampal, MD, PhD¹⁵

¹Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA
²John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
³Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
⁴Division of Hematology & Oncology, Department of Medicine, Shands HealthCare & University of Florida, Gainesville, FL
⁵Department of Medicine, Leukemia Division, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁶University of Arizona Cancer Center, Tucson, AZ
⁷Division of Hematology, Juntendo University School of Medicine, Tokyo, Japan
⁸University of Miyazaki, Miyazaki, Japan
⁹Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita City, Japan
¹⁰Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan
¹¹Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY
¹²Sumitomo Pharma Oncology, Inc., Marlborough, MA
¹³Sumitomo Pharma Oncology, Lehi, UT
¹⁴Sumitomo Pharma Oncology, Inc., Lehi, UT
¹⁵Memorial Sloan Kettering Cancer Center, New York, NY